Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar
2022 · Nature Communications · 231 citations
https://doi.org/10.1038/s41467-022-30895-3
P
Peter Coyle
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
422
Papers
15.7K
Citations
67
h-index
252
i10-index
Peter Coyle is an academic researcher from Queen's University Belfast. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & SARS-CoV-2 detection and testing. The author has an h-index of 67, co-authored 359 publications.
ORCID: 0000-0002-0819-6103Papers by this author
worksCharacterizing the Qatar advanced-phase SARS-CoV-2 epidemic
2021 · Scientific Reports · 165 citations
https://doi.org/10.1038/s41598-021-85428-7
Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination
2021 · International Journal of Infectious Diseases · 100 citations
https://doi.org/10.1016/j.ijid.2021.08.008
Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage
2022 · Nature Communications · 81 citations
https://doi.org/10.1038/s41467-022-32363-4
Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2
2022 · New England Journal of Medicine · 81 citations
https://doi.org/10.1056/nejmc2211055
Real-Time SARS-CoV-2 Genotyping by High-Throughput Multiplex PCR Reveals the Epidemiology of the Variants of Concern in Qatar
2021 · International Journal of Infectious Diseases · 77 citations
https://doi.org/10.1016/j.ijid.2021.09.006
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat